International audiencePurposeIn oropharyngeal cancer adaptive radiation therapy (ART), this study aimed to quantify the dosimetricbenefit of numerous replanning strategies, defined by various numbers and timings of replannings, withregard to parotid gland (PG) sparing.Material and methodsThirteen oropharyngeal cancer patients had one planning and then six weekly CT scans during the sevenweeks of IMRT. Weekly doses were recalculated without replanning or with replanning to spare the PG.Sixty-three ART scenarios were simulated by considering all the combinations of numbers and timings ofreplanning. The PG cumulated doses corresponding to “standard” IMRT and ART scenarios wereestimated and compared, either by calculating the average of weekly ...
Abstract Background Anatomical variations in head and neck cancer during IMRT leads to volume shrink...
Introduction: Radiotherapy in head and neck cancers is treated for several weeks and daily setup and...
AIM OF THE STUDY: To evaluate the dose volume histogram datas in patients diagnosed as stage III/IV...
International audiencePurposeIn oropharyngeal cancer adaptive radiation therapy (ART), this study ai...
Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N...
International audienceBackground: Large anatomical variations occur during the course of intensity-m...
The goal of this study was to evaluate real-time volumetric and dosimetric changes of the parotid gl...
International audienceIntroduction - Large anatomical variations can be observed during the treatmen...
Large anatomical variations can be observed during the treatment course intensity-modulated radiothe...
International audiencePurpose - To guide parotid gland (PG) sparing at the dose planning step, a spe...
Copyright © 2015 Wei-Rong Yao et al. This is an open access article distributed under the Creative C...
PurposeThe practice of deliberately sparing the ipsilateral parotid gland with intensity modulated r...
Purpose: The practice of deliberately sparing the ipsilateral parotid gland with intensity modulated...
Introduction Radiotherapy is a common form of treatment for head-and-neck malignancies. One of the m...
This prospective study of weekly CT scanning and plan adaption during H&N IMRT reports on the freque...
Abstract Background Anatomical variations in head and neck cancer during IMRT leads to volume shrink...
Introduction: Radiotherapy in head and neck cancers is treated for several weeks and daily setup and...
AIM OF THE STUDY: To evaluate the dose volume histogram datas in patients diagnosed as stage III/IV...
International audiencePurposeIn oropharyngeal cancer adaptive radiation therapy (ART), this study ai...
Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N...
International audienceBackground: Large anatomical variations occur during the course of intensity-m...
The goal of this study was to evaluate real-time volumetric and dosimetric changes of the parotid gl...
International audienceIntroduction - Large anatomical variations can be observed during the treatmen...
Large anatomical variations can be observed during the treatment course intensity-modulated radiothe...
International audiencePurpose - To guide parotid gland (PG) sparing at the dose planning step, a spe...
Copyright © 2015 Wei-Rong Yao et al. This is an open access article distributed under the Creative C...
PurposeThe practice of deliberately sparing the ipsilateral parotid gland with intensity modulated r...
Purpose: The practice of deliberately sparing the ipsilateral parotid gland with intensity modulated...
Introduction Radiotherapy is a common form of treatment for head-and-neck malignancies. One of the m...
This prospective study of weekly CT scanning and plan adaption during H&N IMRT reports on the freque...
Abstract Background Anatomical variations in head and neck cancer during IMRT leads to volume shrink...
Introduction: Radiotherapy in head and neck cancers is treated for several weeks and daily setup and...
AIM OF THE STUDY: To evaluate the dose volume histogram datas in patients diagnosed as stage III/IV...